Interesting, page-9

they look effective to me down 40% from 10 to 6 is extremely effective
now they have morgans interested, it would be natural for the stock to rise in value as the FDA is acting speedily to complete the process for the betterment of the industry. This stock should attract certain types of investors such as myself, that would be interested in sharing the risk and reward of a new medical iteration, just to be with it. Far better than resource companies that require 100's mill capital.

its on an ev of 12, the weekly high was 2.4, monthly was 2.6 before breakthrough and its had plenty of continual downramping from one poster advising not to buy because of false reasoning like yours. ( even tweeting to stop people from buying) .

compare to similar stocks this is massively undervalued and should be rerated to the hundreds of mill eventually. not stopping there but continually increasing for a decade or more.

and your reality is not correct. its just an assumption. plenty of stocks raise capital every day and increase in price.